In people with Lynch syndrome, the acquisition of the somatic second hit in normal tissue results in biallelic inactivation of the MMR gene, which is evidenced by loss of MMR protein expression as detected by IHC [24,27], representing the initiation of tumorigenesis. This evidence concerns the gene MRC1 and Lynch syndrome.